Solgar Inc. is voluntarily recalling its ABC Dophilus Powder, after the US Centers for Disease Control found a potentially dangerous fungus present in the product, according to the FDA.
Solgar Inc. is voluntarily recalling its ABC Dophilus Powder, after the US Centers for Disease Control (CDC) found a potentially dangerous fungus present in the product, according to the FDA.
Solgar’s website describes the dietary supplement as a blend of “beneficial friendly bacteria” for infants and children. The powder aims to help maintain a healthy balance within the intestine’s microbial ecology, according to the Solgar website.
However, the CDC found traces of a fungus called Rhizopus oryzae that may cause mucormycosis, a rare infection that can harm pre-mature infants, infants, children, and those with a weakened immune system. It may also affect healthy individuals in rare cases, the FDA stated.
The FDA listed several risk factors for developing mucormycosis, including uncontrolled diabetes, cancer, neutropenia, and skin trauma.
The ABC Dophilus Powder comes with a yellow and beige label and a gold cap. The product has UPC code 0 33984 00010 0; Lot # 074024-01R1, 074024-01, 074024-02 and an expiration date of July 31, 2015.
The FDA is recommending consumers who used the powder to talk to their physician or health care provider.
Individuals who experienced an adverse reaction to the product can report it to the FDA’s MedWatch by downloading a form at www.fda.gov/MedWatch/getforms.htm and submitting it online, or by requesting the form by phone at 1-800-332-1088 and mailing it in or submitting it via fax to 1-800-FDA-0178.